Category: Ovarian Cancer

Home / Clinical Research / Ovarian Cancer
BASKET Study – NC762 in Subjects with Advanced or Metastatic Solid Tumors
Post

BASKET Study – NC762 in Subjects with Advanced or Metastatic Solid Tumors

A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC762 in Subjects with Advanced or Metastatic Solid Tumors This clinical study from NextCure, Inc., is a “first in human testing” study using a drug labeled NC762-01. This study is designed to evaluate the tolerability and benefits of NC762 in increasing doses to subjects with...

BASKET Study – NC318 in Subjects with Advanced or Metastatic Solid Tumors
Post

BASKET Study – NC318 in Subjects with Advanced or Metastatic Solid Tumors

A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC318 in Subjects with Advanced or Metastatic Solid Tumors NC318 is a monoclonal antibody, a first in class immunomedicine that targets Siglec-5 (S15). S15 suppresses the immune system, specifically T cells which fight infection and cancer. NC318 blocks the immune system suppression caused by S15...